GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaNutra SpA (MIL:PHN) » Definitions » Profitability Rank

PharmaNutra SpA (MIL:PHN) Profitability Rank : 8 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is PharmaNutra SpA Profitability Rank?

PharmaNutra SpA has the Profitability Rank of 8. It has a higher profitability and may stay that way.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

PharmaNutra SpA's Operating Margin % for the quarter that ended in Mar. 2024 was 17.31%. As of today, PharmaNutra SpA's Piotroski F-Score is 3.


Competitive Comparison of PharmaNutra SpA's Profitability Rank

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaNutra SpA's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaNutra SpA's Profitability Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaNutra SpA's Profitability Rank distribution charts can be found below:

* The bar in red indicates where PharmaNutra SpA's Profitability Rank falls into.



PharmaNutra SpA Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

PharmaNutra SpA has the Profitability Rank of 8. It has a higher profitability and may stay that way.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

PharmaNutra SpA's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=4.161 / 24.041
=17.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

PharmaNutra SpA has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

Good Sign:

PharmaNutra SpA operating margin is expanding. Margin expansion is usually a good sign.

4. Consistency of the profitability

5. Predictability Rank


PharmaNutra SpA Profitability Rank Related Terms

Thank you for viewing the detailed overview of PharmaNutra SpA's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaNutra SpA (MIL:PHN) Business Description

Traded in Other Exchanges
Address
Via Delle Lenze, 216/b, Pisa, ITA, 56122
PharmaNutra SpA is a pharmaceutical company. It is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. Its products include SiderAL Folic, UltraMag, Cetilar, Gestalys DHA, Bonecal, Nasalt, Novomega, SiderAL, CardioSiderAL, DiKappa2, SiderAL Forte, and others. The company operates in Europe, the Middle East, the Far East, Asia, the United States, and Africa.

PharmaNutra SpA (MIL:PHN) Headlines

No Headlines